CR9269A - Vacunas orales para peces - Google Patents

Vacunas orales para peces

Info

Publication number
CR9269A
CR9269A CR9269A CR9269A CR9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A CR 9269 A CR9269 A CR 9269A
Authority
CR
Costa Rica
Prior art keywords
fish
production
complexes
protein complex
vaccines
Prior art date
Application number
CR9269A
Other languages
English (en)
Inventor
Elisabeth Antonius Florack Dionisius
Jan Bosch Hendrik
Original Assignee
Wageningen Business Generator B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wageningen Business Generator B V filed Critical Wageningen Business Generator B V
Publication of CR9269A publication Critical patent/CR9269A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion tiene que ver con el desarrollo, composicion y produccion de vacunas para las mucosas loralesi de los peces. De forma mas especifica, la invencion es relativa a complejos proteinicos que transportan antigenos a y a traves de las superficies mucosas de los peces para inducir una respuesta inmunitaria, y a la produccion de dichos complejos en una celula hospedadora, preferiblemente vegetal. Se provee el uso de un complejo proteinico que contiene un antigeno de interes fusionado con la subunidad B de la toxina del colera Vibrio cho]erae (CT-B) o de la enterotoxina termolabil Escherichia coli (LT-B) para la fabricacion de una vacuna oral para peces. Se provee tambien alimento para peces que contiene un complejo proteinico de la invencion.
CR9269A 2005-01-26 2007-07-20 Vacunas orales para peces CR9269A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05075203A EP1685848A1 (en) 2005-01-26 2005-01-26 Oral vaccines for fish

Publications (1)

Publication Number Publication Date
CR9269A true CR9269A (es) 2007-11-23

Family

ID=34938018

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9269A CR9269A (es) 2005-01-26 2007-07-20 Vacunas orales para peces

Country Status (8)

Country Link
US (1) US20080274126A1 (es)
EP (2) EP1685848A1 (es)
JP (1) JP2008531478A (es)
AU (1) AU2006209101A1 (es)
CA (1) CA2595913A1 (es)
CR (1) CR9269A (es)
NO (1) NO20074090L (es)
WO (1) WO2006080842A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120088819A1 (en) * 2008-10-31 2012-04-12 Makoto Inoue Method for enhancing expression of recombinant protein
EP2412721A4 (en) 2009-03-26 2012-08-29 Univ Tokyo Nat Univ Corp KOI HERPESVIRUS SPECIFIC ANTIBODY AND ANTIGEN THEREOF
CL2009001197A1 (es) * 2009-05-15 2009-08-21 Farm En Aquacultura Veterinaria Fav S A Composicion farmaceutica veterinaria que contiene la variedad chilena del virus de la anemia infecciosa del salmon, marcadores proteicos y excipientes farmaceuticasmente aceptables; procedimiento de obtencion del virus; uso de la composicion para preparar una vacuna destinada a la prevencion del virus isa.
US8999319B2 (en) * 2010-06-09 2015-04-07 Mississippi State University Oral vaccination of fish with live attenuated Edwardsiella ictaluri vaccines
EP2753686A4 (en) 2011-09-09 2015-06-03 Advanced Bionutrition Corp BIVALENT IPNV ISAV VACCINE USING A VIRUS LIKE PARTICLE PLATFORM AND USE METHOD THEREFOR
CN107056898A (zh) * 2017-02-13 2017-08-18 中国水产科学研究院珠江水产研究所 鲤疱疹病毒3型1301株orf136基因重组表达蛋白、抗体及其应用
CN110747219A (zh) * 2019-11-29 2020-02-04 浙江省淡水水产研究所 一种可添加于饲料中的鲤鱼鲤春病毒血症口服疫苗
BR112022017032A2 (pt) * 2020-02-25 2022-10-11 Migal Galilee Res Institute Ltd Composições compreendendo ltb e antígenos patogênicos, e uso das mesmas.
CN113951183B (zh) * 2021-11-19 2022-10-25 莱州明波水产有限公司 黄带拟鲹亲鱼培育方法
CN118574934A (zh) * 2022-02-11 2024-08-30 因特尔乌斯生物治疗公司 促融合弹状病毒糖蛋白及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354555A (en) * 1985-04-10 1994-10-11 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine to control the viral infection of fish
GB9112553D0 (en) * 1991-06-11 1991-07-31 Wellcome Found Fusion proteins
DE69533964T2 (de) * 1994-10-24 2006-03-30 The Texas A & M University System, College Station Orale immunisierung durch verwendung von transgenen pflanzen
US20030165543A1 (en) * 2000-01-27 2003-09-04 Langridge William H.R. Transgenic plant-based vaccines
WO1999018225A1 (en) * 1997-10-07 1999-04-15 Loma Linda University Expression of cholera toxin b subunit in transgenic plants and efficacy thereof in oral vaccines
EP1522585A1 (en) * 2003-10-09 2005-04-13 Plant Research International B.V. Chimeric carrier molecules for the production of mucosal vaccines

Also Published As

Publication number Publication date
WO2006080842A3 (en) 2006-09-14
JP2008531478A (ja) 2008-08-14
CA2595913A1 (en) 2006-08-03
US20080274126A1 (en) 2008-11-06
EP1685848A1 (en) 2006-08-02
WO2006080842A2 (en) 2006-08-03
AU2006209101A1 (en) 2006-08-03
EP1850868A2 (en) 2007-11-07
NO20074090L (no) 2007-10-24

Similar Documents

Publication Publication Date Title
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1123450T1 (el) Μεθοδος καθαρισμου συζευγματων βασει il-15/il-15ra
MX2021000193A (es) Selección de epítopos de vacunas personalizadas contra el cáncer.
CY1117963T1 (el) Αντισωματα που προσδενουν τα il-17a και il-17f
CO2018005229A2 (es) Vacuna de virus sincitial respiratorio
CO6491045A2 (es) Composiciones de proteina f de virus sincitial respiratorio (rsv) y metodos para producir las mismas
AR088693A1 (es) Anticuerpos especificos para trop-2 y sus usos
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
CY1121535T1 (el) Πρωτεϊνικα κατασκευασματα uspa2 και χρησεις αυτων
UY37279A (es) Anticuerpos tgf-beta y fragmentos de unión de los mismos
AR114565A1 (es) Proteínas de fusión fc il-22 y métodos de uso
PE20212265A1 (es) Bioconjugados de antigenos-polisacaridos de e. coli, metodos de produccion y metodos de utilizacion de los mismos
EA201070200A1 (ru) Композиции, содержащие пневмококковые антигены
AR082149A1 (es) Anticuerpos contra el virus sincicial respiratorio (rsv) humano y metodos para su uso
CY1115030T1 (el) Διειδικα αντι-vegf/αντι-ang-2 αντισωματα
CR20120310A (es) Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
BRPI0915076A2 (pt) composições de vacina, composição imunogênica, método para expressão dos antígenos quiméricos de hpv-hbsag supramencionados, composição farmacêutica, método para ocasionar resposta de anticorpo protetor para composição antigênica e/ou resposta de célula t citotóxica, uso das formulações antigênicas supramencionadas.
EA201590829A1 (ru) Новые мукозные адъюванты и системы доставки
BRPI0621181A8 (pt) Substâncias imunogênicas que compreendem um adjuvante a base de ácido poliinosínico - ácido policitidílico
NO20074090L (no) Orale vaksiner for fisk
MX2023004834A (es) Formulaciones de vacunas de glicoconjugados de expec.
PE20180463A1 (es) Virus de la enteritis del pato y usos del mismo
MX2015011487A (es) Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas.
EA201690115A1 (ru) Комбинированные иммуногенные композиции

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)